Stoke Therapeutics, Inc. (STOK) Earnings Per Share (EPS)
Stoke Therapeutics, Inc. (STOK) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | N/A |
| 2020-12-31 | -$1.56 |
| 2021-12-31 | -$2.34 |
| 2022-12-31 | -$2.60 |
| 2023-12-31 | -$2.38 |
| 2024-12-31 | -$1.65 |
| 2025-12-31 | -$0.12 |
How STOK compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| IMUX | Immunic Inc. | -$0.62 |
| ACHV | Achieve Life Sciences Inc. | -$1.25 |
| IDYA | IDEAYA Biosciences Inc. | -$1.28 |
| VRCA | Verrica Pharmaceuticals Inc. | -$1.68 |
| FLGT | Fulgent Genetics Inc. | -$1.97 |
These are five companies in the same sector as STOK with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Stoke Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("STOK")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STOK | $24.80 | -1.94% | 0.80M |
| 3 | ||||
| 4 | ||||
| 5 |